DDW is delighted to welcome Dr Cathy Tralau-Stewart, Executive Director of The Milner Therapeutics Institute, University of Cambridge to the expert speaker line-up at the DDW Turning Science into Business Symposium.

The event will take place at the Francis Crick Institute in London on Tuesday 4 November.

Dr Cathy Tralau-Stewart
Dr Cathy Tralau-Stewart

Tralau-Stewart will be presenting Connecting academic research with industry to drive therapeutic discoveries.

Dr Cathy Tralau-Stewart is a pharmacologist with experience of academic and industry drug discovery in the UK and USA, ranging from target discovery to early clinical assessment in many therapeutic areas. Her track record includes material involvement in numerous marketed products and candidate compounds.

Tralau-Stewart founded the Drug Discovery Centre, Imperial College London and directed the University of California San Francisco Catalyst Translational Program and was an advisor/ mentor for Stanford University SPARK. She has also held senior leadership positions at Takeda Pharmaceuticals.

Tralau-Stewart will be joined by participants from Cancer Research Horizons-AstraZeneca Functional Genomics Centre, Oxford University, Alzheimer’s Research UK Oxford Drug Discovery Institute, Apollo Therapeutics, University of Cambridge, Gain Therapeutics and Shift Bioscience.

This free half day event will feature:

  • Six in-depth presentations from industry experts
  • A panel discussion examining new processes and technology, with a focus on how they can create efficiencies and expedite the drug discovery process
  • An opportunity for networking

Sponsors:

  • Nuclera (lead sponsor)
  • Collaborative Drug Discovery (coffee break sponsor)
  • Thermo Fisher Scientific (sponsor)

Registration is now open and is subject to availability and eligibility. Secure your place!